NCT00403533View on ClinicalTrials.gov

Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

July 31, 2006

Conditions
Hepatitis C
Interventions
DRUG

20 mg of atorvastatin daily

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00403533 - Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus | Biotech Hunter | Biotech Hunter